1. Long-term effects of highly active antiretroviral therapy in pretreated, vertically HIV type 1-infected children;Resino;6 years of follow-up,2006
2. Prevalence of lipodystrophy in HIV-infected children;Ene;a cross-sectional study,2007
3. Prevalence of metabolic syndrome in HIV-infected patients receiving highly active antiretroviral therapy using International Diabetes Foundation and Adult Treatment Panel III criteria;Samaras;associations with insulin resistance, disturbed body fat compartmentalization, elevated C-reactive protein, and hypoadiponectinemia,2007
4. Longitudinal evaluation and risk factors of lipodystrophy and associated metabolic changes in HIV-infected children;Beregszaszi;J Acquir Immune Defic Syndr,2005
5. Impact on weight and height with the use of HAART in HIV-infected children;Guillen;Pediatr Infect Dis J,2007